# Core B: Clinical Core

> **NIH NIH P30** · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2022 · $656,142

## Abstract

ABSTRACT – CORE B: CLINICAL CORE
The Michigan ADRC Clinical Core (CC) supports and advances research on Alzheimer’s disease and related
dementias (ADRD) through recruitment of a longitudinal cohort (LC), whose deep clinical and biomarker
characterization supports the center’s central theme of identifying, understanding, and modulating the non-
amyloid factors contributing to brain dysfunction and neurodegeneration. The CC will continue to draw on its
robust regional infrastructure to expand the LC from 414 active participants to 550 participants, while
maintaining a focus on individuals at risk for or showing the earliest signs of cognitive decline. We will intensify
our commitment to diversity through continued operation of our successful satellite location in Detroit (~40% of
our LC identifies as Black American) and a planned expansion to the Grand Rapids Hispanic/Latino
community. In conjunction with the Data Management and Statistical (DMSC), Biomarker (BC), and
Neuroimaging (NIC) Cores, we will strengthen available dementia-related research resources by sharing UDS
data, biomarker specimens, and neuroimaging scans with the National Alzheimer’s Coordinating Center and
the National Centralized Repository for Alzheimer’s Disease and Related Dementias. CC activities are guided
by 5 aims. Aim 1 will facilitate and enhance cutting-edge clinical research. The CC will continue to support a
wide range of pharmacologic and non-pharmacologic clinical trials as well as observational studies that span
the dementia spectrum. Continued NIA funding will enhance our capacity to advance ADRD research at the
three partner universities comprising the Michigan ADRC. Aim 2 will enhance diversity in aging and dementia
research. We will build on our successful Detroit satellite model and expand into the Grand Rapids
Hispanic/Latino community. Aim 3 will promote novel biomarker research. The CC will collaborate with the
DMSC, BC and NIC to facilitate the identification and evaluation of low-cost, non-invasive blood-based
biomarkers, through comparison to the A/T/N (and “V” – vascular) classification provided by structural and
metabolic imaging. Aim 4 will enhance participant experience by developing and refining feedback. We have
identified overwhelming interest among our LC participants in learning their clinical and biomarker results. We
will partner with the Outreach, Recruitment, and Engagement Core to ensure ethical disclosure of biomarker
findings and facilitate clinical care as appropriate. Aim 5 will facilitate the training of the next generation of
dementia researchers and clinicians. Collaborating with the Research Education Component, the CC will
leverage the comprehensive resources and diverse training opportunities available for early career
investigators across the campuses of the three participating universities. In summary, the CC will link critical
institutional and regional resources to support multi-disciplinary research, spanning from early detec...

## Key facts

- **NIH application ID:** 10473810
- **Project number:** 5P30AG072931-02
- **Recipient organization:** UNIVERSITY OF MICHIGAN AT ANN ARBOR
- **Principal Investigator:** Benjamin Michael Hampstead
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $656,142
- **Award type:** 5
- **Project period:** 2021-09-01 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10473810

## Citation

> US National Institutes of Health, RePORTER application 10473810, Core B: Clinical Core (5P30AG072931-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10473810. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*